Literature DB >> 28937221

In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.

Mark J Koenigsknecht1, Jason R Baker2, Bo Wen1, Ann Frances1, Huixia Zhang1, Alex Yu1, Ting Zhao1, Yasuhiro Tsume1, Manjunath P Pai3, Barry E Bleske4, Xinyuan Zhang5, Robert Lionberger5, Allen Lee2, Gordon L Amidon1, William L Hasler2, Duxin Sun1.   

Abstract

In vivo drug dissolution in the gastrointestinal (GI) tract is largely unmeasured. The purpose of this clinical study was to evaluate the in vivo drug dissolution and systemic absorption of the BCS class IIa drug ibuprofen under fed and fasted conditions by direct sampling of stomach and small intestinal luminal content. Expanding current knowledge of drug dissolution in vivo will help to establish physiologically relevant in vitro models predictive of drug dissolution. A multilumen GI catheter was orally inserted into the GI tract of healthy human subjects. Subjects received a single oral dose of ibuprofen (800 mg tablet) with 250 mL of water under fasting and fed conditions. The GI catheter facilitated collection of GI fluid from the stomach, duodenum, and jejunum. Ibuprofen concentration in GI fluid supernatant and plasma was determined by LC-MS/MS. A total of 23 subjects completed the study, with 11 subjects returning for an additional study visit (a total of 34 completed study visits). The subjects were primarily white (61%) and male (65%) with an average age of 30 years. The subjects had a median [min, max] weight of 79 [52, 123] kg and body mass index of 25.7 [19.4, 37.7] kg/m2. Ibuprofen plasma levels were higher under fasted conditions and remained detectable for 28 h under both conditions. The AUC0-24 and Cmax were lower in fed subjects vs fasted subjects, and Tmax was delayed in fed subjects vs fasted subjects. Ibuprofen was detected immediately after ingestion in the stomach under fasting and fed conditions until 7 h after dosing. Higher levels of ibuprofen were detected in the small intestine soon after dosing in fasted subjects compared to fed. In contrast to plasma drug concentration, overall gastric concentrations remained higher under fed conditions due to increased gastric pH vs fasting condition. The gastric pH increased to near neutrality after feedingbefore decreasing to acidic levels after 7 h. Induction of the fed state reduced systemic levels but increased gastric levels of ibuprofen, which suggest that slow gastric emptying and transit dominate the effect for plasma drug concentration. The finding of high levels of ibuprofen in stomach and small intestine 7 h post dosing was unexpected. Future work is needed to better understand the role of various GI parameters, such as motility and gastric emptying, on systemic ibuprofen levels in order to improve in vitro predictive models.

Entities:  

Keywords:  clinical study; ibuprofen; immediate release; in vivo dissolution; local gastrointestinal concentration; pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 28937221      PMCID: PMC8851512          DOI: 10.1021/acs.molpharmaceut.7b00425

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  22 in total

Review 1.  Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities.

Authors:  Bart Hens; Maura Corsetti; Robin Spiller; Luca Marciani; Tim Vanuytsel; Jan Tack; Arjang Talattof; Gordon L Amidon; Mirko Koziolek; Werner Weitschies; Clive G Wilson; Roelof J Bennink; Joachim Brouwers; Patrick Augustijns
Journal:  Int J Pharm       Date:  2016-11-30       Impact factor: 5.875

2.  Absorption, distribution and toxicity of ibuprofen.

Authors:  S S Adams; R G Bough; E E Cliffe; B Lessel; R F Mills
Journal:  Toxicol Appl Pharmacol       Date:  1969-09       Impact factor: 4.219

3.  Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract.

Authors:  Alex Yu; Jason R Baker; Ann F Fioritto; Ying Wang; Ruijuan Luo; Siwei Li; Bo Wen; Michael Bly; Yasuhiro Tsume; Mark J Koenigsknecht; Xinyuan Zhang; Robert Lionberger; Gordon L Amidon; William L Hasler; Duxin Sun
Journal:  Mol Pharm       Date:  2016-12-23       Impact factor: 4.939

4.  The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.

Authors:  Yasuhiro Tsume; Deanna M Mudie; Peter Langguth; Greg E Amidon; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2014-01-28       Impact factor: 4.384

Review 5.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

6.  In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases.

Authors:  Brian J Krieg; Seyed Mohammad Taghavi; Gordon L Amidon; Gregory E Amidon
Journal:  J Pharm Sci       Date:  2015-05-15       Impact factor: 3.534

7.  Effect of buffer media composition on the solubility and effective permeability coefficient of ibuprofen.

Authors:  Karl A Levis; Majella E Lane; Owen I Corrigan
Journal:  Int J Pharm       Date:  2003-03-06       Impact factor: 5.875

8.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

9.  The correlation between blood levels of ibuprofen and clinical analgesic response.

Authors:  E M Laska; A Sunshine; I Marrero; N Olson; C Siegel; N McCormick
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

Review 10.  Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs - a systematic review.

Authors:  Robert Andrew Moore; Sheena Derry; Philip J Wiffen; Sebastian Straube
Journal:  Br J Clin Pharmacol       Date:  2015-07-06       Impact factor: 4.335

View more
  18 in total

1.  Measuring pH and Buffer Capacity in Fluids Aspirated from the Fasted Upper Gastrointestinal Tract of Healthy Adults.

Authors:  Chara Litou; Dimitrios Psachoulias; Maria Vertzoni; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2020-01-27       Impact factor: 4.200

2.  "Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy.

Authors:  Bart Hens; Maura Corsetti; Marival Bermejo; Raimar Löbenberg; Pablo M González; Amitava Mitra; Divyakant Desai; Dakshina Murthy Chilukuri; Alexis Aceituno
Journal:  AAPS J       Date:  2019-06-06       Impact factor: 4.009

3.  Dissolution Testing in Drug Product Development: Workshop Summary Report.

Authors:  Andreas Abend; David Curran; Jesse Kuiper; Xujin Lu; Hanlin Li; Andre Hermans; Pramod Kotwal; Dorys A Diaz; Michael J Cohen; Limin Zhang; Erika Stippler; German Drazer; Yiqing Lin; Kimberly Raines; Lawrence Yu; Carrie A Coutant; Haiyan Grady; Johannes Krämer; Sarah Pope-Miksinski; Sandra Suarez-Sharp
Journal:  AAPS J       Date:  2019-01-28       Impact factor: 4.009

4.  Microbial Metabolite Signaling Is Required for Systemic Iron Homeostasis.

Authors:  Nupur K Das; Andrew J Schwartz; Gabrielle Barthel; Naohiro Inohara; Qing Liu; Amanda Sankar; David R Hill; Xiaoya Ma; Olivia Lamberg; Matthew K Schnizlein; Juan L Arqués; Jason R Spence; Gabriel Nunez; Andrew D Patterson; Duxin Sun; Vincent B Young; Yatrik M Shah
Journal:  Cell Metab       Date:  2019-11-07       Impact factor: 27.287

5.  On the Design of Food Effect Studies in Adults for Extrapolating Oral Drug Absorption Data to Infants: an Exploratory Study Highlighting the Importance of Infant Food.

Authors:  Marina Statelova; Konstantinos Goumas; Nikoletta Fotaki; René Holm; Mira Symillides; Christos Reppas; Maria Vertzoni
Journal:  AAPS J       Date:  2019-12-02       Impact factor: 4.009

6.  Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution.

Authors:  Alex Yu; Mark J Koenigsknecht; Bart Hens; Jason R Baker; Bo Wen; Trachette L Jackson; Manjunath P Pai; William Hasler; Gordon L Amidon; Duxin Sun
Journal:  AAPS J       Date:  2019-11-11       Impact factor: 4.009

Review 7.  Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project.

Authors:  Bart Hens; Patrick D Sinko; Nicholas Job; Meagan Dean; Jozef Al-Gousous; Niloufar Salehi; Robert M Ziff; Yasuhiro Tsume; Marival Bermejo; Paulo Paixão; James G Brasseur; Alex Yu; Arjang Talattof; Gail Benninghoff; Peter Langguth; Hans Lennernäs; William L Hasler; Luca Marciani; Joseph Dickens; Kerby Shedden; Duxin Sun; Gregory E Amidon; Gordon L Amidon
Journal:  Int J Pharm       Date:  2018-06-23       Impact factor: 5.875

8.  Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: A multi-compartment stomach approach.

Authors:  Paulo Paixão; Marival Bermejo; Bart Hens; Yasuhiro Tsume; Joseph Dickens; Kerby Shedden; Niloufar Salehi; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Jeffrey Wysocki; Bo Wen; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Gail Benninghoff; Raimar Löbenberg; Arjang Talattof; Duxin Sun; Gordon L Amidon
Journal:  Eur J Pharm Biopharm       Date:  2018-05-29       Impact factor: 5.571

9.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State.

Authors:  Paulo Paixão; Marival Bermejo; Bart Hens; Yasuhiro Tsume; Joseph Dickens; Kerby Shedden; Niloufar Salehi; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Jeffrey Wysocki; Bo Wen; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Gail Benninghoff; Raimar Löbenberg; Arjang Talattof; Duxin Sun; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

10.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.

Authors:  Marival Bermejo; Paulo Paixão; Bart Hens; Yasuhiro Tsume; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Joseph Dickens; Kerby Shedden; Bo Wen; Jeffrey Wysocki; Raimar Löbenberg; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Niloufar Salehi; Arjang Talattof; Gail Benninghoff; Duxin Sun; Gislaine Kuminek; Katie L Cavanagh; Naír Rodríguez-Hornedo; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.